Robeco Institutional Asset Management B.V. Zai Lab LTD Transaction History
Robeco Institutional Asset Management B.V.
- $50.6 Billion
- Q1 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Zai Lab LTD stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 52,035 shares of ZLAB stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,035
Previous 52,035
-0.0%
Holding current value
$1.65 Million
Previous $1.36 Million
38.03%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ZLAB
# of Institutions
156Shares Held
49.8MCall Options Held
103KPut Options Held
439K-
Janus Henderson Group PLC London, X06.57MShares$208 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$204 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$100 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA2.88MShares$91.4 Million0.06% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$79.5 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.1B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...